Pure Global AI
ANVISA registration 80254180463Valid until Mar 04, 2034

CYCLOSPORINE

ANVISA Registration Number: 80254180463PHADIA DIAGNOSTICOS LTDAMICROGENICS CORPORATIONRisk Class III
Verified
Device names
Technical name
CYCLOSPORINE
View exact technical-name matches →
PT: CICLOSPORINA
Commercial name
Família CEDIA Cyclosporine PLUS
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80254180463
Process Number
25351767531202321
CNPJ
04930429000139
Company information
Registration Holder
PHADIA DIAGNOSTICOS LTDA
Manufacturer
MICROGENICS CORPORATION
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Mar 04, 2024
Validity
04/03/2034
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for CYCLOSPORINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180463 and manufactured by MICROGENICS CORPORATION. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Mar 04, 2034.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.